{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:40Z","timestamp":1786980820127,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Centers for Disease Control and Prevention under cooperative agreement of the National Program of Cancer Registries","award":["NU58DP007112"],"award-info":[{"award-number":["NU58DP007112"]}]},{"name":"National Cancer Institute","award":["HHSN2612018000071"],"award-info":[{"award-number":["HHSN2612018000071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To examine incidence trends and patterns for early- and late-onset liver cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Liver and intrahepatic bile duct (IBD) cancers diagnosed between 2000 and 2019 were acquired from 22 SEER registries. Variables included early-onset (20\u201349) vs. late-onset (50+), anatomic subsite, histologic type (hepatocellular carcinoma [HCC] and IBD cholangiocarcinoma [ICC]), sex, and race\/ethnicity. Age-standardized incidence rates were calculated using SEER*Stat. Jointpoint regression analysis was employed to estimate the annual percent change (APC) and the average APC (AAPC) with pairwise comparisons for trend by sex and by race\/ethnicity stratified by age and subsite.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Liver cancer incidence decreased among early-onset (AAPC [95% CI] \u2212\u00a02.39 [\u2212\u00a02.74, \u2212\u00a02.07]) but increased among late-onset patients (2.85 [2.71, 3.01]), primarily driven by HCC (3.60 [3.50, 3.71]). IBD incidence increased for both ages with ICC incidence annually increasing 7.92% (6.84, 9.26) for early-onset and 6.32% (5.46, 8.86) for late-onset patients. Early-onset liver cancer displayed comparable trends across racial\/ethnic groups; however, late-onset liver cancer showed more variation, particularly among American Indian\/Alaska Native\/Asian Pacific Islander (AI\/AN\/API) populations, which experienced a significant decrease in incidence, thereby narrowing the gap with other racial\/ethnic groups. For IBD, an identical pattern of early-onset IBD among non-Hispanic Blacks (NHBs) compared to Hispanics was showed with coincidence test\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.1522, and a parallel pattern was observed among late-onset patients for both sexes\u00a0(\n                      <jats:italic>p<\/jats:italic>\n                      = 0.5087).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Late-onset HCC continues to rise, except for NHB and AI\/AN\/API, where incidence rates have started to decrease over the past 4\u20135\u00a0years. Early and late-onset ICC incidence continues to increase across all racial\/ethnic groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10552-024-01955-4","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:09:32Z","timestamp":1736402972000},"page":"551-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Temporal trends and patterns for early- and late-onset adult liver cancer incidence vary by race\/ethnicity, subsite, and histologic type in the United States from 2000 to 2019"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-1225","authenticated-orcid":false,"given":"Mei-Chin","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra L.","family":"Ratnapradipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"6","key":"1955_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77(6):1598\u20131606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021","journal-title":"J Hepatol"},{"issue":"1","key":"1955_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F (2020) Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159(1):335-349.e15. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.068","journal-title":"Gastroenterology"},{"issue":"1","key":"1955_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21037\/jgo-23-25","volume":"14","author":"Z Yao","year":"2023","unstructured":"Yao Z, Dai C, Yang J, Xu M, Meng H, Hu X, Lin N (2023) Time-trends in liver cancer incidence and mortality rates in the US from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database. J Gastrointest Oncol 14(1):312\u2013324. https:\/\/doi.org\/10.21037\/jgo-23-25","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"1955_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics. CA: Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA: Cancer J Clin"},{"issue":"12","key":"1955_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/jnci\/djz106","volume":"111","author":"EM Ward","year":"2019","unstructured":"Ward EM, Sherman RL, Henley SJ, Jemal A, Siegel DA, Feuer EJ, Firth AU, Kohler BA, Scott S, Ma J, Anderson RN, Benard V, Cronin KA (2019) Annual report to the nation on the status of cancer, featuring cancer in men and women age 20\u201349 years. JNCI J Natl Cancer Inst 111(12):1279\u20131297. https:\/\/doi.org\/10.1093\/jnci\/djz106","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"10","key":"1955_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, Kawachi I, Campbell PT, Giovannucci EL, Weiderpass E, Rebbeck TR, Ogino S (2022) Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol 19(10):656\u2013673. https:\/\/doi.org\/10.1038\/s41571-022-00672-8","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1955_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, Zhu Y, Wan Z, Larsson SC, Tsilidis KK, Dunlop MG, Campbell H, Rudan I, Song P, Theodoratou E, Ding K, Li X (2023) Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol 2(1):e000049. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049","journal-title":"BMJ Oncol"},{"issue":"8","key":"1955_CR8","doi-asserted-by":"publisher","first-page":"e2328171","DOI":"10.1001\/jamanetworkopen.2023.28171","volume":"6","author":"B Koh","year":"2023","unstructured":"Koh B, Tan DJ, Ng CH, Fu CE, Lim WH, Zeng RW, Yong JN, Koh JH, Syn N, Meng W, Wijarnpreecha K, Liu K, Chong CS, Muthiah M, Luu HN, Vogel A, Singh S, Yeoh KG, Loomba R, Huang DQ (2023) Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019. JAMA Netw Open 6(8):e2328171. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28171","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1955_CR9","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"E Heer","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM (2020) Global burden and trends in premenopausal and postmenopausal breast cancer: a population- based study. Lancet Glob Health 8(8):e1027\u2013e1037. https:\/\/doi.org\/10.1016\/S2214-109X(20)30215-1","journal-title":"Lancet Glob Health"},{"issue":"2","key":"1955_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/cncr.33916","volume":"128","author":"RR Shah","year":"2021","unstructured":"Shah RR, Millien VO, da Costa Jr WL, Oluyomi AO, Gould Suarez M, Thrift AP (2021) Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001through 2017. Cancer 128(2):299\u2013310. https:\/\/doi.org\/10.1002\/cncr.33916","journal-title":"Cancer"},{"issue":"3","key":"1955_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","volume":"160","author":"J Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, Ng K, Chong C, Zheng ZJ, Wong MC (2021) Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology 160(3):744\u2013754. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.007","journal-title":"Gastroenterology"},{"issue":"1","key":"1955_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/1055-9965.EPI-20-0944","volume":"30","author":"DC Codipilly","year":"2021","unstructured":"Codipilly DC, Sawas T, Dhaliwal L, Johnson ML, Lansing R, Wang KK, Leggett CL, Katzka DA, Iyer PG (2021) Epidemiology and outcomes of young-onset esophageal adenocarcinoma: an analysis from a population-based database. Cancer Epidemiol Biomark Prev 30(1):142\u2013149. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0944","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1955_CR13","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. https:\/\/seer.cancer.gov\/about\/overview.html. Accessed 10 Jun 2024"},{"key":"1955_CR14","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (https:\/\/www.seer.cancer.gov) SEER*Stat Database: Incidence\u2014SEER Research Plus Limited-Field Data, 22 Registries, Nov 2023 Sub (2000\u20132021)\u2014Linked to County Attributes - Total U.S., 1969\u20132022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission. Accessed on 5 Mar 2024"},{"key":"1955_CR15","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program ((https:\/\/www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Limited-Field Data with Delay-Adjustment, 22 Registries, Malignant Only, Nov 2023 Sub (2000\u20132021)\u2014Linked To County Attributes\u2014Total U.S., 1969\u20132022 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024, based on the November 2023 submission"},{"key":"1955_CR16","unstructured":"SEER site record: https:\/\/seer.cancer.gov\/siterecode\/. Accessed 5 Apr 2024"},{"issue":"3","key":"1955_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335\u2013351. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(20000215)19:3%3c335::AID-SIM336%3e3.0.CO;2-Z","journal-title":"Stat Med"},{"issue":"3","key":"1955_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/jamaoncol.2020.7600","volume":"7","author":"Z Bakouny","year":"2021","unstructured":"Bakouny Z, Paciotti M, Schmidt AL, Lipsitz SR, Choueiri TK, Trinh QD (2021) Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol 7(3):458\u2013460. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7600","journal-title":"JAMA Oncol"},{"issue":"11","key":"1955_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.43796","volume":"6","author":"AK Lofters","year":"2023","unstructured":"Lofters AK, Wu F, Frymire E, Kiran T, Vahabi M, Green ME, Glazier RH (2023) Cancer screening disparities before and after the COVID-19 pandemic. JAMA Netw Open 6(11):e2343796. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.43796","journal-title":"JAMA Netw Open"},{"key":"1955_CR20","unstructured":"SEER*Stat software version 8.4.3. https:\/\/seer.cancer.gov\/seerstat\/"},{"issue":"6","key":"1955_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0962280206070621","volume":"15","author":"RC Tiwari","year":"2006","unstructured":"Tiwari RC, Clegg LX, Zou Z (2006) Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 15(6):547\u2013569. https:\/\/doi.org\/10.1177\/0962280206070621","journal-title":"Stat Methods Med Res"},{"key":"1955_CR22","unstructured":"Joinpoint Trend Analysis Software version 5.1.0. https:\/\/surveillance.cancer.gov\/joinpoint\/"},{"issue":"5","key":"1955_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000508568","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Yan L, Liu Y, Qu C, Ni J, Li H (2020) The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017. Liver Cancer 9(5):563\u2013582. https:\/\/doi.org\/10.1159\/000508568","journal-title":"Liver Cancer"},{"issue":"9","key":"1955_CR24","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States From 1975 to 2005. J Clin Oncol 27(9):1485\u20131491. https:\/\/doi.org\/10.1200\/JCO.2008.20.7753","journal-title":"J Clin Oncol"},{"issue":"3","key":"1955_CR25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cgh.2023.08.016","volume":"22","author":"PS Pinheiro","year":"2024","unstructured":"Pinheiro PS, Jones PD, Medina H, Cranford HM, Koru-Sengul T, Bungum T, Wong R, Kobetz EN, McGlynn KA (2024) Incidence of etiology-specific hepatocellular carcinoma: diverging trends and significant heterogeneity by race and ethnicity. Clin Gastroenterol Hepatol 22(3):562\u2013571. https:\/\/doi.org\/10.1016\/j.cgh.2023.08.016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1955_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep4.1457","volume":"4","author":"H Bradley","year":"2020","unstructured":"Bradley H, Hall EW, Rosenthal EM, Sullivan PS, Ryerson AB, Rosenberg ES (2020) Hepatitis C virus prevalence in 50 U.S. states and D.C. by sex, birth cohort, and race: 2013\u20132016. Hepatol Commun 4(3):355\u2013370. https:\/\/doi.org\/10.1002\/hep4.1457","journal-title":"Hepatol Commun"},{"issue":"12","key":"1955_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jnci\/djj234","volume":"98","author":"TM Welzel","year":"2006","unstructured":"Welzel TM, McGlynn KA, Hsing AW, O\u2019Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873\u2013875. https:\/\/doi.org\/10.1093\/jnci\/djj234","journal-title":"J Natl Cancer Inst"},{"key":"1955_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, Briiks GA (2016) Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist 21:594\u2013599. https:\/\/doi.org\/10.1634\/theoncologist.2015-0446","journal-title":"Oncologist"},{"issue":"10","key":"1955_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","volume":"27","author":"M Javle","year":"2022","unstructured":"Javle M, Lee S, Azad NS, Borad MJ, Kelly RK, Sivaraman A et al (2022) Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017. Oncologist 27(10):874\u2013883. https:\/\/doi.org\/10.1093\/oncolo\/oyac150","journal-title":"Oncologist"},{"issue":"4","key":"1955_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3889\/oamjms.2015.111","volume":"3","author":"D Janevsak","year":"2015","unstructured":"Janevsak D, Chaloska-Ivanova V, Janevsk V (2015) Hepatocellular carcinoma: risk factors, diagnosis and treatment. Open Access Maced J Med Sci 3(4):732\u2013736. https:\/\/doi.org\/10.3889\/oamjms.2015.111","journal-title":"Open Access Maced J Med Sci"},{"issue":"11","key":"1955_CR31","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn P, Ahmed A, Kim D (2021) Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 15(11):1295\u20131307. https:\/\/doi.org\/10.1080\/17474124.2021.1991792","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"1955_CR32","first-page":"1205","volume":"8","author":"Y Li","year":"2015","unstructured":"Li Y, Zhang Z, Shi J, Jin L, Wang L, Xu D, Wang FS (2015) Risk factors for naturally occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China. Int J Clin Exp Med 8(1):1205\u20131212","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"1955_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/ijc.22283","volume":"120","author":"TM Welzel","year":"2006","unstructured":"Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, Ghormli LE, Olsen JH, McGlynn KA (2006) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 120(3):638\u2013641. https:\/\/doi.org\/10.1002\/ijc.22283","journal-title":"Int J Cancer"},{"issue":"2","key":"1955_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","volume":"6","author":"A Gupta","year":"2017","unstructured":"Gupta A, Dixon E (2017) Epidemiology and risk factors: intrahepatic cholangiocarcinoma. Hepatob Surg Nutr 6(2):101\u2013104. https:\/\/doi.org\/10.21037\/hbsn.2017.01.02","journal-title":"Hepatob Surg Nutr"},{"issue":"11","key":"1955_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/jnci\/djaa007","volume":"112","author":"S Gupta","year":"2020","unstructured":"Gupta S, Harper A, Ruan Y, Barr R, Frazier AL, Ferlay J, Steliarova-Foucher E, Fidler-Benaoudia MM (2020) International trends in the incidence of cancer among adolescents and young adults. JNCI: J Natl Cancer Inst 112(11):1105\u20131117. https:\/\/doi.org\/10.1093\/jnci\/djaa007","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"1","key":"1955_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.24351","volume":"54","author":"GL Tyson","year":"2011","unstructured":"Tyson GL, El-Serag HB (2011) Risk factors of cholangiocarcinoma. Hepatology 54(1):173\u2013184. https:\/\/doi.org\/10.1002\/hep.24351","journal-title":"Hepatology"},{"issue":"4","key":"1955_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3889\/oamjms.2015.111","volume":"3","author":"D Janevska","year":"2015","unstructured":"Janevska D, Chaloska-Ivanova V, Janevski V (2015) Hepatocellular carcinoma: risk factors, diagnosis and treatment. Open Access Maced J Med Sci 3(4):732\u2013736. https:\/\/doi.org\/10.3889\/oamjms.2015.111","journal-title":"Open Access Maced J Med Sci"},{"key":"1955_CR38","doi-asserted-by":"publisher","unstructured":"Niu ZS, Niu XJ, Wang WH (2016) Genetic alterations in hepatocellular carcinoma: an update. World J Gastroenterol 22(41):9069\u20139095. https:\/\/doi.org\/10.3748\/wjg.v22.i41.9069. http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i41\/9069.htm","DOI":"10.3748\/wjg.v22.i41.9069"},{"key":"1955_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13059-014-0436-9","volume":"15","author":"S Jhunjhunwala","year":"2014","unstructured":"Jhunjhunwala S, Jiang Z, Stawiski EW, Gnad F, Liu J, Mayba O, Du P, Diao J, Johnson S, Wong KF, Gao Z, Li Y, Wu TD et al (2014) Diverse modes of genomic alteration in hepatocellular carcinoma. Genome Biol 15:436. https:\/\/doi.org\/10.1186\/s13059-014-0436-9","journal-title":"Genome Biol"},{"key":"1955_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ng.2256","volume":"44","author":"C Guichard","year":"2012","unstructured":"Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E et al (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44:694\u2013698. https:\/\/doi.org\/10.1038\/ng.2256","journal-title":"Nat Genet"},{"issue":"5","key":"1955_CR41","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1245\/s10434-024-15013-5","volume":"31","author":"DI Tsilimigras","year":"2024","unstructured":"Tsilimigras DI, Han X, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Chaucy F, Groot Koerkamp B, Endo I, Sasaki K, Aucejo F, Zhang XF, Zhu H, Pawlik TM (2024) Early onset intrahepatic cholangiocarcinoma: clinical characteristics, oncological outcomes, and genomic\/transcriptomic features. Ann Surg Oncol 31(5):3087\u20133097. https:\/\/doi.org\/10.1245\/s10434-024-15013-5","journal-title":"Ann Surg Oncol"},{"issue":"469","key":"1955_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1198\/016214504000001899","volume":"100","author":"DN Midthune","year":"2005","unstructured":"Midthune DN, Fay MP, Clegg LX, Feuer EJ (2005) Modeling reporting delays and reporting corrections in cancer registry data. J Am Stat Assoc 100(469):61\u201370. https:\/\/doi.org\/10.1198\/016214504000001899","journal-title":"J Am Stat Assoc"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-024-01955-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01955-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:03:29Z","timestamp":1744232609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-024-01955-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1955"],"URL":"https:\/\/doi.org\/10.1007\/s10552-024-01955-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involving human subjects was reviewed and approved by the institutional review board of the Louisiana State University Health Sciences Center\u2014New Orleans. We use SEER public research data, so written informed consent for participation was not required for this study in accordance with national legislation and institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}